Leuven, Belgium I October 2019
.
miDiagnostics has agreed a partnership with Notified Body, BSI (the Netherlands) to assess and certify the miDiagnostics Quality Systems to ISO 13485 (2016) in preparation for the CE marking and 510(k) clearance of the miDiagnostics range of diagnostic devices.
miDiagnostics is developing a new generation of disposable tests that require only drops of blood and allow detection of cells, proteins, nucleic acids, and/or small molecules.
Its core technology is a novel silicon-based nanofluidic processor that automatically processes the blood sample without the need of pumps or valves.
There is no need for complex and costly instrumentation enabling medical decisions to be taken at the point of need or remote areas with a high level of comfort to both patients and caregivers.
“We are very delighted to announce our readiness for this next key phase of our development. This partnership with BSI brings us one key step nearer to the market,”
Ben Chambers, VP Quality and Regulatory Affairs
Share this story
About miDIAGNOSTICS
